OTCGREY
GEDSF

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt

Prices are adjusted according to historical splits.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Stock Price

Vitals

Today's Low:
$19.45
Today's High:
$19.45
Open Price:
$19.45
52W Low:
$18.45
52W High:
$22.95
Prev. Close:
$22.95
Volume:
80

Company Statistics

Market Cap.:
$4.56 billion
Book Value:
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$460.46 billion
Profit Margin:
12.85%
Return on Assets TTM:
9.39%
Return on Equity TTM:
10.75%

Company Profile

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt had its IPO on under the ticker symbol GEDSF.

The company operates in the sector and industry. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt has a staff strength of 12,167 employees.

Stock update

Shares of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt opened at $19.45 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $19.45 - $19.45, and closed at $19.45.

This is a -15.25% slip from the previous day's closing price.

A total volume of 80 shares were traded at the close of the day’s session.

In the last one week, shares of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt have slipped by -12.78%.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's Key Ratios

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt has a market cap of $4.56 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt’s revenue was $0 with a gross profit of $460.46 billion and an EBITDA of $0. The EBITDA ratio measures Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt’s operating margin was 0% while its return on assets stood at 9.39% with a return of equity of 10.75%.

In Q3, Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt’s quarterly earnings growth was a negative -62.3% while revenue growth was a positive 5.6%.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt’s profitability.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt stock pays annual dividends of $0 per share, indicating a yield of 1.13% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0
Total Liabilities
$171.00 billion
Operating Cash Flow
$-27985000000.00
Capital Expenditure
$18.08 billion
Dividend Payout Ratio
0%

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt ended 2024 with $0 in deferred long-term liabilities, $171.00 billion in other current liabilities, 18638000000.00 in common stock, $1,007.85 billion in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt’s total current assets stands at $602.15 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $264.54 billion compared to accounts payable of $40.49 billion and inventory worth $170.22 billion.

In 2024, Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's operating cash flow was $-27985000000.00 while its capital expenditure stood at $18.08 billion.

Comparatively, Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$19.45
52-Week High
$22.95
52-Week Low
$18.45
Analyst Target Price
$

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt stock is currently trading at $19.45 per share. It touched a 52-week high of $22.95 and a 52-week low of $22.95. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $24.15 and 200-day moving average was $24.21 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt

The stock symbol (also called stock or share ticker) of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt is GEDSF

The IPO of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt took place on

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail. It develops and manufactures products in various therapeutic areas, including women’s healthcare, cardiovascular, and central nervous system. The company offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and aesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, an emergency contraceptive pill; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound care; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergy; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; Oralsept, a sore throat and local anesthetic. Further, it provides financial and accounting, social and welfare, portfolio and project management, catering, carriage transportation, engineering, quality control, trading, asset management, and biotechnological services. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary.

Address

GyOemroi Ut 19-21., Budapest, Hungary, 1103